{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:53:51Z","timestamp":1781654031212,"version":"3.54.5"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T00:00:00Z","timestamp":1778544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Schmerz"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00482-026-00943-8","type":"journal-article","created":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T06:53:03Z","timestamp":1778568783000},"page":"233-242","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Schmerztherapie w\u00e4hrend der Schwangerschaft","Pain management during pregnancy"],"prefix":"10.1007","volume":"40","author":[{"given":"Wolfgang E.","family":"Paulus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,12]]},"reference":[{"issue":"12","key":"943_CR1","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1161\/CIRCULATIONAHA.122.061934","volume":"147","author":"EJ Ward","year":"2023","unstructured":"Ward\u00a0EJ, Bert\u00a0S, Fanti\u00a0S, Malone\u00a0KM, Maughan\u00a0RT, Gkantsinikoudi\u00a0C, Prin\u00a0F, Volpato\u00a0LK, Piovezan\u00a0AP, Graham\u00a0GJ, Dufton\u00a0NP, Perretti\u00a0M, Marelli-Berg\u00a0FM, Nadkarni\u00a0S (2023) Placental Inflammation Leads to Abnormal Embryonic Heart Development. Circulation 147(12):956\u2013972","journal-title":"Circulation"},{"issue":"12","key":"943_CR2","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1097\/j.pain.0000000000000637","volume":"157","author":"AL Stone","year":"2016","unstructured":"Stone\u00a0AL, Wilson\u00a0AC (2016) Transmission of risk from parents with chronic pain to offspring: an integrative conceptual model. Pain 157(12):2628\u20132639","journal-title":"Pain"},{"key":"943_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18041503","volume":"18","author":"L Grazzi","year":"2021","unstructured":"Grazzi\u00a0L, Toppo\u00a0C, D\u2019Amico\u00a0D, Leonardi\u00a0M, Martelletti\u00a0P, Raggi\u00a0A et\u00a0al (2021) Non-pharmacological approaches to headaches: non-invasive neuromodulation, nutraceuticals, and behavioral approaches. Int J Environ Res Public Health 18:1503","journal-title":"Int J Environ Res Public Health"},{"key":"943_CR4","doi-asserted-by":"crossref","unstructured":"Bremer\u00a0L et al (2017) Insights on Intake Frequencies, Dosages and Effects on Hematopoietic Stem Cell Populations in Cord Blood From a Longitudinal Prospective Pregnancy Cohort. EBioMedicine 26:146-151","DOI":"10.1016\/j.ebiom.2017.10.023"},{"issue":"2","key":"943_CR5","doi-asserted-by":"publisher","first-page":"178. e1","DOI":"10.1016\/j.ajog.2007.08.040","volume":"198","author":"C Rebordosa","year":"2008","unstructured":"Rebordosa\u00a0C et\u00a0al (2008) Acetaminophen use during pregnancy: effects on risk for congenital abnormalities. Am J Obstet Gynecol 198(2):178. e1\u2013178. e7","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"943_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/AOG.0b013e3181c52616","volume":"115","author":"ML Feldkamp","year":"2010","unstructured":"Feldkamp\u00a0ML et\u00a0al (2010) Acetaminophen use in pregnancy and risk of birth defects: findings from the National Birth Defects Prevention Study. Obstet Gynecol 115(1):109\u2013115","journal-title":"Obstet Gynecol"},{"issue":"8","key":"943_CR7","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1093\/aje\/kwy086","volume":"187","author":"R Masarwa","year":"2018","unstructured":"Masarwa\u00a0R, Levine\u00a0H, Gorelik\u00a0E, Reif\u00a0S, Perlman\u00a0A, Matok\u00a0I (2018) Prenatal Exposure to Acetaminophen and Risk for Attention Deficit Hyperactivity Disorder and Autistic Spectrum Disorder: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Cohort Studies. Am J Epidemiol 187(8):1817\u20131827","journal-title":"Am J Epidemiol"},{"issue":"1","key":"943_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12940-025-01208-0","volume":"24","author":"D Prada","year":"2025","unstructured":"Prada\u00a0D, Ritz\u00a0B, Bauer\u00a0AZ, Baccarelli\u00a0AA (2025) Evaluation of the evidence on acetaminophen use and neurodevelopmental disorders using the Navigation Guide methodology. Environ Health 24(1):56\u201356","journal-title":"Environ Health"},{"key":"943_CR9","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/s41574-021-00553-7","volume":"12","author":"AZ Bauer","year":"2021","unstructured":"Bauer\u00a0AZ, Swan\u00a0SH, Kriebel\u00a0D et\u00a0al (2021) Paracetamol use during pregnancy \u2014 a call for precautionary action. Nat Rev Endocrinol 12:757\u2013766","journal-title":"Nat Rev Endocrinol"},{"key":"943_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/ppe.12615","volume":"34","author":"R Masarwa","year":"2020","unstructured":"Masarwa\u00a0R, Platt\u00a0RW, Filion\u00a0KB (2020) Acetaminophen Use during pregnancy and the risk of attention deficit hyperactivity disorder: a causal association or bias? Paediatr Perinat Epidemiol 34:309\u2013317","journal-title":"Paediatr Perinat Epidemiol"},{"key":"943_CR11","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-3840","volume":"140","author":"E Ystr\u00f8m","year":"2017","unstructured":"Ystr\u00f8m\u00a0E, Gustavson\u00a0K, Brandlistuen\u00a0RE et\u00a0al (2017) Prenatal exposure to acetaminophen and risk of ADHD. Pediatrics 140:e20163840","journal-title":"Pediatrics"},{"issue":"14","key":"943_CR12","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1001\/jama.2024.3172","volume":"331","author":"VH Ahlqvist","year":"2024","unstructured":"Ahlqvist\u00a0VH, Sj\u00f6qvist\u00a0H, Dalman\u00a0C et\u00a0al (2024) Acetaminophen Use During Pregnancy and Children\u2019s Risk of Autism, ADHD, and Intellectual Disability. JAMA 331(14):1205\u20131214","journal-title":"JAMA"},{"key":"943_CR13","doi-asserted-by":"crossref","unstructured":"Okubo Y, Hayakawa I, Sugitate R, Nariai H. Maternal Acetaminophen Use and Offspring\u2019s Neurodevelopmental Outcome: A\u00a0Nationwide Birth Cohort Study. Paediatr Perinat Epidemiol. 2025 Sep 2","DOI":"10.1111\/ppe.70071"},{"key":"943_CR14","doi-asserted-by":"crossref","unstructured":"D\u2019Antonio F, Flacco ME, L D Valle, et\u00a0al. Prenatal paracetamol exposure and child neurodevelopment: a\u00a0systematic review and meta-analysis. Lancet Obstet Gynaecol Womens Health 2026; published online Jan 16","DOI":"10.1016\/S3050-5038(25)00211-0"},{"issue":"1","key":"943_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/j.1651-2227.2010.01942.x","volume":"100","author":"E Bakkeheim","year":"2011","unstructured":"Bakkeheim\u00a0E, Mowinckel\u00a0P, Carlsen\u00a0KH, H\u00e5land\u00a0G, Carlsen\u00a0KC (2011) Paracetamol in early infancy: the risk of childhood allergy and asthma. Acta Paediatr 100(1):90\u201396","journal-title":"Acta Paediatr"},{"issue":"5","key":"943_CR16","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01090-2018","volume":"53","author":"SO Shaheen","year":"2019","unstructured":"Shaheen\u00a0SO, Lundholm\u00a0C, Brew\u00a0BK, Almqvist\u00a0C (2019) Prescribed analgesics in pregnancy and risk of childhood asthma. Eur Respir\u00a0J 53(5):1801090","journal-title":"Eur Respir J"},{"issue":"3","key":"943_CR17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/BOR.0000000000000054","volume":"26","author":"BL Bermas","year":"2014","unstructured":"Bermas\u00a0BL (2014) Non-steroidal anti inflammatory drugs, glucocorticoids and disease modifying anti-rheumatic drugs for the management of rheumatoid arthritis before and during pregnancy. Curr Opin Rheumatol 26(3):334\u2013340","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"943_CR18","doi-asserted-by":"publisher","first-page":"B41","DOI":"10.1016\/j.ajog.2022.09.001","volume":"228","author":"R Silver","year":"2023","unstructured":"Silver\u00a0R et\u00a0al (2023) Society for Maternal-Fetal Medicine Consult Series #64: systemic lupus erythematosus in pregnancy. Am J Obstet Gynecol 228(3):B41\u2013B60","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"943_CR19","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1007\/s00482-021-00571-4","volume":"35","author":"D Marhofer","year":"2021","unstructured":"Marhofer\u00a0D, Jaksch\u00a0W, Aigm\u00fcller\u00a0T, Jochberger\u00a0S, Urlesberger\u00a0B, Pils\u00a0K, Maier\u00a0B, Likar\u00a0R, Kayer\u00a0B, Wallner\u00a0R, Fink\u00a0P, Gr\u00f6gl\u00a0G (2021) Schmerztherapie in der Schwangerschaft: Eine expertInnenbasierte interdisziplin\u00e4re Konsensus-Empfehlung. Schmerz 35(6):382\u2013390","journal-title":"Schmerz"},{"key":"943_CR20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1056\/NEJMoa1704559","volume":"377","author":"DL Rolnik","year":"2017","unstructured":"Rolnik\u00a0DL, Wright\u00a0D, Poon\u00a0LC et\u00a0al (2017) Aspirin versus Place bo in Pregnancies at High Risk for Preterm Preeclampsia. N\u00a0Engl J Med 377:613\u2013622","journal-title":"N Engl J Med"},{"key":"943_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejogrb.2021.05.017","volume":"262","author":"R Man","year":"2021","unstructured":"Man\u00a0R et\u00a0al (2021) Aspirin for preventing adverse outcomes in low risk nulliparous women with singleton pregnancies: a\u00a0systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol 262:105\u2013112","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"1","key":"943_CR22","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/OGX.0b013e31815e8731","volume":"63","author":"AH James","year":"2008","unstructured":"James\u00a0AH, Brancazio\u00a0LR, Price\u00a0T (2008) Aspirin and reproductive outcomes. Obstet Gynecol Surv 63(1):49\u201357","journal-title":"Obstet Gynecol Surv"},{"issue":"15","key":"943_CR23","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1503\/cmaj.110454","volume":"183","author":"HR Nakhai-Pour","year":"2011","unstructured":"Nakhai-Pour\u00a0HR et\u00a0al (2011) Use of nonaspirin nonsteroidal anti-inflammatory drugs during pregnancy and the risk of spontaneous abortion. Cmaj 183(15):1713\u20131720","journal-title":"Cmaj"},{"key":"943_CR24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.reprotox.2018.05.003","volume":"79","author":"K Dathe","year":"2018","unstructured":"Dathe\u00a0K et\u00a0al (2018) No evidence of adverse pregnancy outcome after exposure to ibuprofen in the first trimester - evaluation of the national Embryotox cohort. Reprod Toxicol 79:32\u201338","journal-title":"Reprod Toxicol"},{"issue":"4","key":"943_CR25","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/bcp.12653","volume":"80","author":"S Daniel","year":"2015","unstructured":"Daniel\u00a0S, Koren\u00a0G, Lunenfeld\u00a0E, Levy\u00a0A (2015) NSAIDs and spontaneous abortions - true effect or an indication bias? Br J Clin Pharmacol 80(4):750\u2013754","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"943_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02992-z","volume":"19","author":"S Baldacci","year":"2024","unstructured":"Baldacci\u00a0S et\u00a0al (2024) Medication use during pregnancy and the risk of gastroschisis: a systematic review and meta-analysis of observational studies. Orphanet J Rare Dis 19(1):31","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"943_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/j.1471-0528.1990.tb01807.x","volume":"97","author":"SK Hendricks","year":"1990","unstructured":"Hendricks\u00a0SK et\u00a0al (1990) Oligohydramnios associated with prostaglandin synthetase inhibitors in preterm labour. Br J Obstet Gynaecol 97(4):312\u2013316","journal-title":"Br J Obstet Gynaecol"},{"key":"943_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.reprotox.2024.108561","volume":"125","author":"X Chen","year":"2024","unstructured":"Chen\u00a0X, Yang\u00a0Y, Chen\u00a0L, Wang\u00a0K (2024) Pregnancy outcomes and birth defects in offspring following Non-steroidal anti-inflammatory drugs exposure during pregnancy: A systematic review and meta-analysis. Reprod Toxicol 125:108561","journal-title":"Reprod Toxicol"},{"key":"943_CR29","doi-asserted-by":"crossref","unstructured":"Hultzsch\u00a0S et al (2021) First trimester naproxen exposure and outcome of pregnancy\u00a0- A German case series. Reprod Toxicol. 103:51-57","DOI":"10.1016\/j.reprotox.2021.05.006"},{"issue":"3","key":"943_CR30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00404-008-0707-3","volume":"279","author":"T da Silva Dal Pizzol","year":"2009","unstructured":"da Silva Dal Pizzol\u00a0T, Schuler-Faccini\u00a0L, Mengue\u00a0SS, Fischer\u00a0MI (2009) Dipyrone use during pregnancy and adverse perinatal events. Arch Gynecol Obstet 279(3):293\u2013297","journal-title":"Arch Gynecol Obstet"},{"issue":"5","key":"943_CR31","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/00001648-199609000-00015","volume":"7","author":"CR Sharpe","year":"1996","unstructured":"Sharpe\u00a0CR, Franco\u00a0EL (1996) Use of dipyrone during pregnancy and risk of Wilms\u2019 tumor. Epidemiology 7(5):533\u2013535","journal-title":"Epidemiology"},{"issue":"10","key":"943_CR32","first-page":"722","volume":"8","author":"A Weintraub","year":"2006","unstructured":"Weintraub\u00a0A, Mankuta\u00a0D (2006) Dipyrone-induced oligohydramnios and ductus arteriosus restriction. Isr Med Assoc\u00a0J 8(10):722\u2013723","journal-title":"Isr Med Assoc J"},{"issue":"12","key":"943_CR33","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.1158\/1055-9965.EPI-06-0031","volume":"15","author":"MS Pombo-de-Oliveira","year":"2006","unstructured":"Pombo-de-Oliveira\u00a0MS, Koifman\u00a0S, Brazilian Collaborative Study Group of Infant Acute Leukemia (2006) Infant acute leukemia and maternal exposures during pregnancy. Cancer Epidemiol Biomarkers Prev 15(12):2336\u20132341","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"943_CR34","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/1552-6909.12487","volume":"43","author":"UA Pritham","year":"2014","unstructured":"Pritham\u00a0UA, McKay\u00a0L (2014) Safe management of chronic pain in pregnancy in an era of opioid misuse and abuse. J\u00a0Obstet Gynecol Neonatal Nurs 43(5):554\u2013567","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"key":"943_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s40267-016-0359-5","volume":"33","author":"AM Writers","year":"2017","unstructured":"Writers\u00a0AM (2017) Manage chronic pain during pregnancy with selected analgesics. Drugs Ther Perspect 33:62\u201365","journal-title":"Drugs Ther Perspect"},{"issue":"12","key":"943_CR36","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00228-011-1069-5","volume":"67","author":"K Nezvalov\u00e1-Henriksen","year":"2011","unstructured":"Nezvalov\u00e1-Henriksen\u00a0K, Spigset\u00a0O, Nordeng\u00a0H (2011) Effects of codeine on pregnancy outcome: results from a large population-based cohort study. Eur J Clin Pharmacol 67(12):1253\u20131261","journal-title":"Eur J Clin Pharmacol"},{"key":"943_CR37","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/bcpt.12497","volume":"118","author":"D Lassen","year":"2015","unstructured":"Lassen\u00a0D, Ennis\u00a0ZN, Damkier\u00a0P (2015) First-trimester pregnancy exposure to venlafaxine or duloxetine and risk of major congenital malformations: a systematic review. Basic Clin Pharmacol Toxicol 118:32\u201336","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"943_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0845-1","volume":"15","author":"AA Veroniki","year":"2017","unstructured":"Veroniki\u00a0AA et\u00a0al (2017) Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes. BMC Med 15(1):95","journal-title":"BMC Med"},{"issue":"9","key":"943_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003322","volume":"17","author":"E Patorno","year":"2020","unstructured":"Patorno\u00a0E et\u00a0al (2020) Gabapentin in pregnancy and the risk of adverse neonatal and maternal outcomes: a population-based cohort study nested in the US Medicaid Analytic eXtract dataset. PLoS Med 17(9):e1003322","journal-title":"PLoS Med"},{"issue":"6","key":"943_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-034829","volume":"10","author":"PO Blotiere","year":"2020","unstructured":"Blotiere\u00a0PO et\u00a0al (2020) Risk of early neurodevelopmental outcomes associated with prenatal exposure to the antiepileptic drugs most commonly used during pregnancy: a\u00a0French nationwide population-based cohort study. BMJ Open 10(6):e034829","journal-title":"BMJ Open"},{"issue":"24","key":"943_CR41","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1212\/WNL.0000000000002767","volume":"86","author":"U Winterfeld","year":"2016","unstructured":"Winterfeld\u00a0U et\u00a0al (2016) Pregnancy outcome following maternal exposure to pregabalin may call for concern. Neurology 86(24):2251\u20132257","journal-title":"Neurology"},{"issue":"21","key":"943_CR42","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1212\/WNL.0000000000003959","volume":"88","author":"E Patorno","year":"2017","unstructured":"Patorno\u00a0E et\u00a0al (2017) Pregabalin use early in pregnancy and the risk of major congenital malformations. Neurology 88(21):2020\u20132025","journal-title":"Neurology"},{"issue":"7","key":"943_CR43","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s40264-023-01307-2","volume":"46","author":"E Dudukina","year":"2023","unstructured":"Dudukina\u00a0E et\u00a0al (2023) Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a\u00a0population-based cohort study in four Nordic countries. Drug Saf 46(7):661\u2013675","journal-title":"Drug Saf"},{"issue":"5","key":"943_CR44","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/jamaneurol.2024.0258","volume":"81","author":"D Battino","year":"2024","unstructured":"Battino\u00a0D, Tomson\u00a0T, Bonizzoni\u00a0E, Craig\u00a0J, Perucca\u00a0E, Sabers\u00a0A, Thomas\u00a0S, Alvestad\u00a0S, Perucca\u00a0P, Vajda\u00a0F, EURAP Collaborators (2024) Risk of Major Congenital Malformations and Exposure to Antiseizure Medication Monotherapy. JAMA Neurol 81(5):481\u2013489","journal-title":"JAMA Neurol"},{"issue":"4","key":"943_CR45","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/head.12500","volume":"55","author":"A Marchenko","year":"2015","unstructured":"Marchenko\u00a0A, Etwel\u00a0F, Olutunfese\u00a0O, Nickel\u00a0C, Koren\u00a0G, Nulman\u00a0I (2015) Pregnancy outcome following prenatal exposure to triptan medications: a\u00a0meta-analysis. Headache 55(4):490\u2013501","journal-title":"Headache"},{"key":"943_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2025.108546","volume":"266","author":"K Gulati","year":"2025","unstructured":"Gulati\u00a0K, Wagle Shukla\u00a0A, Pandey\u00a0S (2025) Is the use of botulinum toxin injection for treating neurological disorders safe during pregnancy and lactation? Toxicon 266:108546","journal-title":"Toxicon"},{"issue":"50","key":"943_CR47","volume":"119","author":"L Witt","year":"2022","unstructured":"Witt\u00a0L, Ciplea\u00a0A, Thiel\u00a0S, Hellwig\u00a0K (2022) Kinderwunsch, Schwangerschaft und Stillzeit: Prophylaxe und -therapie der Migr\u00e4ne umstellen. Dtsch Arztebl 119(50):6","journal-title":"Dtsch Arztebl"},{"issue":"7","key":"943_CR48","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1001\/jamaneurol.2022.1269","volume":"79","author":"MH Bj\u00f8rk","year":"2022","unstructured":"Bj\u00f8rk\u00a0MH, Zoega\u00a0H, Leinonen\u00a0MK, Cohen\u00a0JM, Dreier\u00a0JW, Furu\u00a0K, Gilhus\u00a0NE, Gissler\u00a0M, H\u00e1lfd\u00e1narson \u00d3, Igland\u00a0J, Sun\u00a0Y, Tomson\u00a0T, Alvestad\u00a0S, Christensen\u00a0J (2022) Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability. JAMA Neurol 79(7):672\u2013681","journal-title":"JAMA Neurol"}],"container-title":["Der Schmerz"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-026-00943-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00482-026-00943-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00482-026-00943-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:06:42Z","timestamp":1781651202000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00482-026-00943-8"}},"subtitle":["Eine Gratwanderung zwischen Nutzen und Risiko","A\u00a0balancing act between benefits and risks"],"short-title":[],"issued":{"date-parts":[[2026,5,12]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["943"],"URL":"https:\/\/doi.org\/10.1007\/s00482-026-00943-8","relation":{},"ISSN":["0932-433X","1432-2129"],"issn-type":[{"value":"0932-433X","type":"print"},{"value":"1432-2129","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,12]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autorinnen und Autoren sowie die Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"W. E. Paulus\n                      : A.\u00a0Finanzielle Interessen: Referentenhonorare f\u00fcr Fortbildungsveranstaltungen zu Risiken einer Arzneimitteltherapie in Schwangerschaft und Stillzeit von Bezirks\u00e4rztekammer Nordw\u00fcrttemberg, ITF Pharma GmbH, Janssen-Cilag GmbH, Landesapothekerkammer Baden-W\u00fcrttemberg, Lundbeck GmbH, Novartis Pharma GmbH, PHOENIX Pharmahandel GmbH & Co KG, UCB Pharma GmbH, Exeltis Germany GmbH, Reckitt Benckiser Deutschland GmbH, Jenapharm GmbH & Co. KG. \u2013\u00a0Einmaliges Beratungsgespr\u00e4ch zu Risiken eines Medikaments in der Schwangerschaft bei Desitin Arzneimittel GmbH, Exeltis Germany GmbH, axunio Pharma GmbH.\u00a0\u2013 B. Nichtfinanzielle Interessen: Leiter der Beratungsstelle f\u00fcr Reproduktionstoxikologie\/Oberarzt der Universit\u00e4tsfrauenklinik Ulm | ordentliches Mitglied der Arzneimittelkommission der deutschen \u00c4rzteschaft | Mitgliedschaft in folgenden Fachgesellschaften: Deutsche Gesellschaft f\u00fcr Gyn\u00e4kologie und Geburtshilfe, Deutsche Gesellschaft f\u00fcr Ultraschall in der Medizin, European Network of Teratology Information Services, Deutsche Gesellschaft f\u00fcr Perinatale Medizin, Deutsche Gesellschaft f\u00fcr Pr\u00e4natal- und Geburtsmedizin, Bayerische Gesellschaft f\u00fcr Geburtshilfe und Frauenheilkunde.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autorinnen und Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}